NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1679554588 MD PHD
Verify on CMS → Matthew Smith, MD PHD
Medical Oncology Physician in Boston, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
391
Medicare Part D claims · 65 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
36%
generic claims · 64% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$58.2K
33 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Matthew Smith, MD PHD filed 391 Medicare Part D claims in 2024 as a Medical Oncology Physician in Boston, Massachusetts, prescribing 36% generic.
- 391
- Part D claims, 2024
- 36%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Smith, MD PHD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1679554588), first enumerated 11/08/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 391 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$58.2K in reported industry payments (33 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Matthew Smith, MD PHD's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1679554588 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1679554588
- ENUM-LEGACY 2005
- TAX-NARROW 4,028
- RX-LIGHT 391
- BOOK-THIN 317 in Massachusetts
- PHOTO-ENUM Craig Deligdish · 2005
Matthew Smith, MD PHD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
391 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Matthew Smith, MD PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Smith, MD PHD?
Quality data not reportedPrimary specialty
Medical Oncology Physician
Medicare Part D claims
391 47% vs specialty avg
Specialty distribution in Massachusetts
How Medical Oncology Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1679554588 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD PHD |
| Gender | Male |
| NPI Issued | 11/08/2005 |
Hospital and facility affiliations
Facilities where Matthew Smith, MD PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Massachusetts General Physicians Organization Inc
Boston, MA
The General Hospital Corporation
Waltham, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Smith, MD PHD. Source: openpaymentsdata.cms.gov.
Total received
$58.2K
Largest payer
Bayer Healthcare Pharmaceuticals Inc.
Most common payment type
Travel and Lodging
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Matthew Smith, MD PHD. To verify Matthew Smith, MD PHD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Matthew Smith, MD PHD - brand share 64.0%
Medical Oncology Physician average
64% brand-name claims vs 36% generic, on 391 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
391
Total Claims
$3.4M
Total Drug Cost
65
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 481
- Total Day Supply
- 14,185
- Brand vs Generic
- 64% brand / 36% generic
- Brand Drug Cost
- $3.2M
- Generic Drug Cost
- $219K
Patient Demographics
- Average Patient Age
- 76.7 years
- Avg HCC Risk Score
- 1.75
- Gender Split
- 0% female / 100% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Smith, MD PHD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Nubeqa
Nubeqa
187 claims
- Abiraterone Acetate
Abiraterone Acetate
76 claims
- Xtandi 46
Xtandi
46 claims
- Prednisone 32
Prednisone
32 claims
- Orgovyx 13
Orgovyx
13 claims
| Drug | Claims |
|---|---|
| Nubeqa Darolutamide | 187 |
| Abiraterone Acetate | 76 |
| Xtandi Enzalutamide | 46 |
| Prednisone | 32 |
| Orgovyx Relugolix | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Matthew Smith, MD PHD fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Matthew Smith, MD PHD's 391 claims are below the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Smith, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Smith.
One of 317 Medical Oncology Physician providers enrolled in Massachusetts, 5 are shown here.
Dr. Janet Abrahm
MD
Boston, MA
Dr. Thomas Abrams
M.D.
Boston, MA
Dr. Jeremy Abramson
MD
Boston, MA
Dr. Jose Acevedo Mejia
M.D.
Boston, MA
Dr. Adeboye Adewoye
M.D.
Boston, MA
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Smith, MD PHD's specialty? ▼
Matthew Smith, MD PHD specializes in Medical Oncology Physician and practices in Boston, Massachusetts. Credentials: MD PHD.
How much does Matthew Smith, MD PHD prescribe under Medicare Part D? ▼
In 2024, Matthew Smith, MD PHD wrote 391 Medicare Part D claims totaling $3.4M in drug costs for 65 beneficiaries.
Where is Matthew Smith, MD PHD located? ▼
Matthew Smith, MD PHD is located at 100 BLOSSOM ST, Boston, MA, 02114. Phone: (617) 724-5257.
What is Matthew Smith, MD PHD's NPI number? ▼
Matthew Smith, MD PHD's National Provider Identifier (NPI) is 1679554588, issued on 11/08/2005.
Does Matthew Smith, MD PHD prescribe more brand-name or generic drugs? ▼
Matthew Smith, MD PHD's prescribing is 64% brand-name and 36% generic drugs by claim count, with $3.2M in brand drug costs.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Matthew Smith, MD PHD prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Smith, MD PHD's most frequently prescribed drugs include Nubeqa, Abiraterone Acetate, Xtandi. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Smith, MD PHD accept Medicare? ▼
Matthew Smith, MD PHD appears in CMS Medicare data with 391 Part D claims and 65 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Smith, MD PHD's credentials? ▼
Matthew Smith, MD PHD's NPI is 1679554588 with credentials MD PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.